Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study K Kario, N Sun, FT Chiang, O Supasyndh, SH Baek, A Inubushi-Molessa, ... Hypertension 63 (4), 698-705, 2014 | 266 | 2014 |
Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20 K Kalantar-Zadeh, O Supasyndh, RS Lehn, CJ McAllister, JD Kopple Journal of renal nutrition 13 (1), 15-25, 2003 | 185 | 2003 |
Sericin cream reduces pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled experimental study P Aramwit, O Keongamaroon, T Siritientong, N Bang, O Supasyndh BMC nephrology 13 (1), 1-11, 2012 | 91 | 2012 |
Exertional heatstroke: early recognition and outcome with aggressive combined cooling—a 12-year experience P Sithinamsuwan, K Piyavechviratana, T Kitthaweesin, W Chusri, ... Military medicine 174 (5), 496-502, 2009 | 82 | 2009 |
Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus B Satirapoj, S Tassanasorn, M Charoenpitakchai, O Supasyndh PLoS One 10 (4), e0124055, 2015 | 80 | 2015 |
Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population B Satirapoj, P Limwannata, A Chaiprasert, O Supasyndh, P Choovichian BMC nephrology 14 (1), 1-5, 2013 | 79 | 2013 |
Efficacy and safety of sacubitril/valsartan (LCZ696) compared with olmesartan in elderly Asian patients (≥ 65 Years) with systolic hypertension O Supasyndh, J Wang, K Hafeez, Y Zhang, J Zhang, H Rakugi American Journal of Hypertension 30 (12), 1163-1169, 2017 | 76 | 2017 |
Effect of oral anabolic steroid on muscle strength and muscle growth in hemodialysis patients O Supasyndh, B Satirapoj, P Aramwit, D Viroonudomphol, A Chaiprasert, ... Clinical Journal of the American Society of Nephrology 8 (2), 271-279, 2013 | 66 | 2013 |
Relationship between serum uric acid levels with chronic kidney disease in a Southeast Asian population B Satirapoj, O Supasyndh, A Chaiprasert, P Ruangkanchanasetr, ... Nephrology 15 (2), 253-258, 2010 | 65 | 2010 |
A randomized controlled study of dose-finding, efficacy, and safety of mulberry leaves on glycemic profiles in obese persons with borderline diabetes T Thaipitakwong, O Supasyndh, Y Rasmi, P Aramwit Complementary therapies in medicine 49, 102292, 2020 | 63 | 2020 |
Electrolyte disturbances and risk factors of acute kidney injury patients receiving dialysis in exertional heat stroke B Satirapoj, S Kongthaworn, P Choovichian, O Supasyndh BMC nephrology 17 (1), 1-6, 2016 | 57 | 2016 |
Efficacy of mulberry leaf tablets in patients with mild dyslipidemia P Aramwit, K Petcharat, O Supasyndh Phytotherapy Research 25 (3), 365-369, 2011 | 53 | 2011 |
Simple and sensitive high-performance liquid chromatographic method for the determination of mycophenolic acid in plasma K Na-Bangchang, O Supasyndh, T Supaporn, V Banmairuroi, J Karbwang Journal of Chromatography B: Biomedical Sciences and Applications 738 (1 …, 2000 | 48 | 2000 |
Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: a prospective cohort study B Satirapoj, P Pooluea, N Nata, O Supasyndh Journal of Diabetes and its Complications 33 (9), 675-681, 2019 | 44 | 2019 |
Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension O Supasyndh, N Sun, K Kario, K Hafeez, J Zhang Hypertension Research 40 (5), 472-476, 2017 | 43 | 2017 |
Urinary angiotensinogen as a potential biomarker of diabetic nephropathy B Satirapoj, N Siritaweesuk, O Supasyndh Clinical kidney journal 7 (4), 354-360, 2014 | 43 | 2014 |
Obesity and its relation to chronic kidney disease: A population‐based, cross‐sectional study of a T hai army population and relatives B Satirapoj, O Supasyndh, N Mayteedol, D Punpanich, A Chaiprasert, ... Nephrology 18 (3), 229-234, 2013 | 43 | 2013 |
The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309 K Praditpornsilpa, P Kupatawintu, W Mongkonsritagoon, O Supasyndh, ... Nephrology Dialysis Transplantation 24 (5), 1545-1549, 2009 | 43 | 2009 |
Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V> 3.6 O Supasyndh, B Satirapoj, S Seenamngoen, S Yongsiri, P Choovichian, ... J Med Assoc Thai 92 (5), 624-31, 2009 | 42 | 2009 |
Novel tubular biomarkers predict renal progression in type 2 diabetes mellitus: a prospective cohort study B Satirapoj, K Aramsaowapak, T Tangwonglert, O Supasyndh Journal of Diabetes Research 2016, 2016 | 40 | 2016 |